The newly launched biotech is equipped with rights to a trio of weight loss medicines licensed from China-based Sciwind ...

Just when you thought there couldn’t be investor appetite for yet another GLP-1-focused obesity biotech, Verdiva Bio has ...

INR:2093. rummy 11 circle app download The number of cross-provincial direct settlements for medical treatment exceeded 4.24 million, and the officia ...

In its pursuit of a cancer drug for pancreatic cancer and possibly ovarian cancer, Amplia has history on its side.

Investor interest in companies with obesity candidates in their pipeline clearly remains high, given that a brand new ...

coolbet logo PNAS: Antibiotics could treat opioid addiction GlaxoSmithKline signs 150 million euro partnership to develop next-generation mRNA COVID-19 vaccine Beyond the limits of human eyes! AI ...

In a report released on January 9, David Evans from Kepler Capital maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a ...

GSK PLC GSK shares were unchanged Friday at £13.50, on what proved to be an all-around grim trading session for the stock ...

In a report released today, James Gordon from J.P. Morgan reiterated a Sell rating on GlaxoSmithKline (GSK – Research Report). The company’s ...

Shares of GSK PLC GSK inched down 0.77% to £13.50 Thursday, on what proved to be an all-around positive trading session for ...

Biotech company 23andMe had a rough 2024, including a $30 million settlement payment after customer data was compromised.

GSK and Pfizer's respiratory syncytial virus (RSV) vaccines will carry warnings that they can increase the risk of developing ...